Adagio Therapeutics, Inc. (ADGI) Cash Flow Annual - Discounting Cash Flows
ADGI
Adagio Therapeutics, Inc.
ADGI (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2021
12-31
Report Filing: 2022-08-15 2022-03-31
Net Income/Starting Line -291.7 -226.8
Cash From Operating Activities -170.8 -184.7
Depreciation and Amortization 0.415 1.43
Deferred Income Tax 0 0
Stock Based Compensation 14.33 17.76
Other Non-Cash Items 79.24 0.067
Changes in Working Capital 26.99 22.79
Accounts Receivable 0 0
Inventory 0 0
Accounts Payable 15.19 -2.37
Deferred Revenue 11.8 25.16
Other Working Capital 0 0
Cash From Investing Activities 48.93 -50.71
Investments in Property Plant and Equipment -0.017 -0.084
Payments for Acquisitions 0 0
Purchases of Securities -0.189 -188.6
Sales and Maturities of Investments 49.14 138
Other Investing Activities 0 0
Cash From Financing Activities 329.1 662.7
Debt Repayment 0 0
Common Stock Issued 0.335 335.2
Common Stock Repurchased -0.004 0
Dividends Paid 0 0
Other Financing Activities 329.1 662.7
Effect of Forex Changes on Cash -0.113 0
Net Change in Cash -3.38 427.2
Cash at Beginning of Period 478.3 115
Cash at End of Period 474.9 542.2
Free Cash Flow -170.8 -184.8
Operating Cash Flow -170.8 -184.7
Capital Expenditure -0.017 -0.084
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us